Actinogen Medical

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.

Contact Details

Suite 901, Level 9 , 109 Pitt St SYDNEY NSW 2000
02 8964 7401
www.actinogen.com.au

Lists and Charts

Share price

Actinogen Medical
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
625th Aquirian 14.29% 0%
626th Globe International 14.18% 27.3%
627th Actinogen Medical 14.13% -8.42%
628th Central Petroleum 13.97% -20.17%
629th Alterity Therapeutics 13.95% -30.54%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Company Share Transactions

04/11/24
$50.00k Issued
Actinogen Medical
04/11/24
$1.00m Issued
Actinogen Medical
04/11/24
Issued
Actinogen Medical
Total value as at the date of the transaction
Powered by Morningstar ®

    Related Information

    Access to our data for Actinogen Medical is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Actinogen Medical is included in 1 list - Public Companies - non WA.

    For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

    Subscribe today

    X